nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency
|
Khazal, Sajad |
|
|
128 |
5 |
p. 735-737 |
artikel |
2 |
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma
|
Han, Ming |
|
|
128 |
5 |
p. 732-735 |
artikel |
3 |
BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans
|
Wu, Song |
|
|
128 |
5 |
p. 699-709 |
artikel |
4 |
Bone marrow smear examination in the diagnosis of Niemann-Pick B disease
|
Foucher, Barbara |
|
|
128 |
5 |
p. 738 |
artikel |
5 |
Critical requirement of VEGF-C in transition to fetal erythropoiesis
|
Fang, Shentong |
|
|
128 |
5 |
p. 710-720 |
artikel |
6 |
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
|
Bolzoni, Marina |
|
|
128 |
5 |
p. 667-679 |
artikel |
7 |
Editorial Board
|
|
|
|
128 |
5 |
p. i |
artikel |
8 |
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A
|
Mahlangu, Johnny |
|
|
128 |
5 |
p. 630-637 |
artikel |
9 |
FBXO11: a novel germinal center B-cell regulator?
|
Elenitoba-Johnson, Kojo S.J. |
|
|
128 |
5 |
p. 611-612 |
artikel |
10 |
FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease
|
Schneider, Christof |
|
|
128 |
5 |
p. 660-666 |
artikel |
11 |
Florid erythrophagocytosis by neutrophils in peripheral blood
|
Li, Weijie |
|
|
128 |
5 |
p. 739 |
artikel |
12 |
Freireich EJ, Miller A, Emerson CP, Ross JF. The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood. 1957;12(11):972-983.
|
|
|
|
128 |
5 |
p. 607 |
artikel |
13 |
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
|
Hope, Chelsea |
|
|
128 |
5 |
p. 680-685 |
artikel |
14 |
I'm TORC1-ing platelets and thromboembolism
|
Munday, Adam D. |
|
|
128 |
5 |
p. 609-610 |
artikel |
15 |
Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice
|
Shaw, Maureen A. |
|
|
128 |
5 |
p. 721-731 |
artikel |
16 |
Mechanisms of platelet-mediated liver regeneration
|
Lisman, Ton |
|
|
128 |
5 |
p. 625-629 |
artikel |
17 |
mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation
|
Yang, Jun |
|
|
128 |
5 |
p. 615-624 |
artikel |
18 |
ROS: novel regulators of thrombopoiesis
|
Zhang, Bing |
|
|
128 |
5 |
p. 613-614 |
artikel |
19 |
Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes
|
Koide, Shuhei |
|
|
128 |
5 |
p. 638-649 |
artikel |
20 |
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
|
Metzeler, Klaus H. |
|
|
128 |
5 |
p. 686-698 |
artikel |
21 |
Versican vs versikine: tolerance vs attack
|
Schmitt, Michael |
|
|
128 |
5 |
p. 612-613 |
artikel |
22 |
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination
|
IJspeert, Hanna |
|
|
128 |
5 |
p. 650-659 |
artikel |